Equity Profile

COR

Cencora, Inc.

Health CareHealth Care Distributors$59.6B

Feb3Thu

Pre-Earnings Brief

UpcomingQ3-2026Pre-Market9:00 AM EST

Company Snapshot

Cencora, Inc. is a key player in the health care distribution sector, focusing on delivering essential medical products and services....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a critical measure of a company's profitability and is closely watched by investors.

N/A

Revenue Growth

Revenue growth indicates how well the company is expanding its business and capturing market share.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

COR Q3-2026 Earnings Preview

Context

Company Snapshot

Cencora, Inc. is a key player in the health care distribution sector, focusing on delivering essential medical products and services. With a market cap of $60 billion, the company plays a vital role in ensuring that healthcare providers have access to necessary supplies, which is increasingly important as healthcare demands grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+3.76%

Avg Stock Reaction

-1.64%

Last Quarter Recap

In Q2-2026, Cencora reported an EPS of $4.75, slightly below expectations of $4.80, resulting in a stock drop of 17.38% the following day. The company continues to navigate a challenging market environment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Cencora's upcoming earnings are cautious, given the recent EPS miss and stock volatility. Investors are looking for signs of recovery and improvement in profitability.

Bull Case

If Cencora can exceed EPS estimates and show strong revenue growth, it could signal a turnaround and restore investor confidence, potentially leading to a stock rebound.

Bear Case

Conversely, if the company misses expectations again or fails to provide a clear path to recovery, it could lead to further declines in stock price, as investors may lose faith in management's ability to execute.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q3-2026, and how does it compare to previous quarters?

Given the recent EPS miss, investors will closely scrutinize this figure to gauge the company's recovery and profitability.

What guidance does management provide for revenue growth moving forward?

Clear guidance on revenue growth is crucial for investor confidence, especially after recent performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Cencora's potential for recovery, as recent operational improvements could lead to better-than-expected results this quarter.

Supporting Evidence

Cencora has historically beaten EPS estimates 88% of the time, suggesting potential for a positive surprise.

The options market is pricing a smaller move than historical averages, indicating a lack of confidence that could work in the company's favor.

Recent operational changes may not yet be reflected in analyst expectations, leading to a potential upside.

Key Risk

If the EPS exceeds $4.85, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter centers around whether Cencora can regain profitability and growth momentum after recent misses.

Bull Confirmed If

An EPS of $4.85 or higher would confirm the bull case, indicating a strong recovery.

Bear Confirmed If

An EPS below $4.50 would confirm the bear case, signaling ongoing struggles.

Pre-Earnings Positioning

Options Market

Implied Move

±0.94%

Historical Avg

±5.6%

Pricing cheap

The options market is pricing a relatively small move around the earnings report, indicating uncertainty among investors.

Options are pricing a 0.94% move, while the stock has averaged a 5.6% move historically, suggesting a potentially undervalued setup.

Detail

ATM IV

0.3%

30d HV

60.2%

Calls (13K)P/C Ratio: 0.19Puts (105K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing cheap setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cencora beats expectations, history suggests a potential stock increase of around 0.61%, confirming a positive turnaround narrative.

In-Line / Cautious

If the results are in line with expectations, the stock may remain stable, but cautious management commentary could lead to volatility.

Miss

A miss could lead to a significant decline, with history suggesting an average drop of 17.38% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on margins.
2Details on new partnerships or contracts that could drive revenue growth.
3Insights into market demand trends for healthcare products.
4Management's outlook on competitive pressures in the distribution sector.
5Any commentary on regulatory changes that could affect operations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Cirrus Logic, Inc.

Company Snapshot

Cencora, Inc. is a key player in the health care distribution sector, focusing on delivering essential medical products and services....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a critical measure of a company's profitability and is closely watched by investors.

N/A

Revenue Growth

Revenue growth indicates how well the company is expanding its business and capturing market share.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

COR Q3-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+3.76%

Avg Stock Reaction

-1.64%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Cencora's upcoming earnings are cautious, given the recent EPS miss and stock volatility. Investors are looking for signs of recovery and improvement in profitability.

Bull Case

If Cencora can exceed EPS estimates and show strong revenue growth, it could signal a turnaround and restore investor confidence, potentially leading to a stock rebound.

Bear Case

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q3-2026, and how does it compare to previous quarters?

Given the recent EPS miss, investors will closely scrutinize this figure to gauge the company's recovery and profitability.

What guidance does management provide for revenue growth moving forward?

Clear guidance on revenue growth is crucial for investor confidence, especially after recent performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Cencora's potential for recovery, as recent operational improvements could lead to better-than-expected results this quarter.

Supporting Evidence

Cencora has historically beaten EPS estimates 88% of the time, suggesting potential for a positive surprise.

The options market is pricing a smaller move than historical averages, indicating a lack of confidence that could work in the company's favor.

Recent operational changes may not yet be reflected in analyst expectations, leading to a potential upside.

Key Risk

If the EPS exceeds $4.85, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter centers around whether Cencora can regain profitability and growth momentum after recent misses.

Bull Confirmed If

An EPS of $4.85 or higher would confirm the bull case, indicating a strong recovery.

Bear Confirmed If

An EPS below $4.50 would confirm the bear case, signaling ongoing struggles.

Pre-Earnings Positioning

Options Market

Implied Move

±0.94%

Historical Avg

±5.6%

Pricing cheap

The options market is pricing a relatively small move around the earnings report, indicating uncertainty among investors.

Options are pricing a 0.94% move, while the stock has averaged a 5.6% move historically, suggesting a potentially undervalued setup.

Detail

ATM IV

0.3%

30d HV

60.2%

Calls (13K)P/C Ratio: 0.19Puts (105K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing cheap setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cencora beats expectations, history suggests a potential stock increase of around 0.61%, confirming a positive turnaround narrative.

In-Line / Cautious

If the results are in line with expectations, the stock may remain stable, but cautious management commentary could lead to volatility.

Miss

A miss could lead to a significant decline, with history suggesting an average drop of 17.38% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on margins.
2Details on new partnerships or contracts that could drive revenue growth.
3Insights into market demand trends for healthcare products.
4Management's outlook on competitive pressures in the distribution sector.
5Any commentary on regulatory changes that could affect operations.